In humans and animals, it has shown no toxicity and good tolerability [23, 28]
Key properties: Stimulates GH release from the pituitary (not the hypothalamus) Does not significantly raise cortisol or prolactin Short half-life (~2 hours) produces a sharp, pulsatile GH release Does not block somatostatin (the hormone that inhibits GH release) Selective for GH minimal effect on other hormones The selectivity is what makes ipamorelin the preferred GHRP for most protocols
Related Resources AOD-9604 complete research guide Best peptides for weight loss research CJC-1295 & Ipamorelin growth hormone guide Peptide half-life chart What is bacteriostatic water Peptide side effects overview How to choose a research peptide supplier All PSPeptides products are sold exclusively for laboratory and research use
Positioning of DPP-4 Inhibitors in the Treatment Algorithm of type 2 Diabetes In 2018 the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) published a new joint position statement for the treatment of type 2 diabetes (70, 71)
They are also preferred over older diabetes medications due to their favorable effects on blood sugar regulation and their low risk of hypoglycemia (low blood sugar), as well as their proven benefit for cardiovascular risk reduction
It is crucial for the patient to carefully follow these instructions to ensure the medication works effectively and as expected